4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001144204-08-042578
Options or other derivatives
- Chief Financial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ZAREF ANDREW Chief Financial Officer | 2008-07-14 | Grant or award · Options to Purchase Common Stock | +200,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X03/v120091_ex.xml…